中文 | English
Return
Total: 294 , 1/30
Show Home Prev Next End page: GO
Author:( Lian YIN)

1.The ethical requirement of the placebo-controlled clinical study

Fengmei LIAN ; Haibo YIN

Chinese Medical Ethics 1994;0(06):-

2.Research progress in inhibition of corneal neovascularization by anti-VEGF therapy

Jia-yin, WANG ; Bi-lian, KE

Journal of Shanghai Jiaotong University(Medical Science) 2009;29(7):886-889

3.Recent Advances in Biological Control of Pest Insects by Using Viruses in China

Xiu-lian, SUN ; Hui-yin, PENG

Virologica Sinica 2007;22(2):158-162

4.Cloning and expression of immunotoxin DT389- hbFGF

Lian-Rong, YIN ; Jia-Qin, YUAN

International Eye Science 2007;7(1):15-18

5.Combining allogenic conjunctiva transplantation with amniotic membrane transplantation for conjunctiva alkali burns in early-stage

Lian-Rong, YIN ; Fa-Ming, HUANG

International Eye Science 2005;5(6):1093-1096

6.The Illness Burden Brought by Atrial Fibrillation in China

Lian ZHANG ; Chunyue YIN ; Shanlian HU

Chinese Health Economics 2013;(12):5-7

7.Study on the relativity among the attachment type, alexitymia and defense style of depression patients

Yin YUAN ; Wenjun MAO ; Lian LU

Chinese Journal of Behavioral Medicine and Brain Science 2012;21(1):44-46

8.Study on Effective Polysaccharide of Anti-Human Lung Cancer A549 Cells in Zhou’s Prescription for Resolving Mass

Meiping YANG ; Lian YIN ; Xu ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2006;0(05):-

9.Study on Components of Effective Parts Ⅰ in Zhou's Prescription of Anti-Human Lung Cancer on A549 Cells

Jing DONG ; Lian YIN ; Xu ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2006;0(11):-

10.Influence of Zhenweifang on Muscle Tension in Flaccid Paralysis Period and Prognosis of Stroke

Lingxia LIAN ; Chunping YIN ; Changyin WANG

Chinese Journal of Information on Traditional Chinese Medicine 2006;0(06):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 294 , 1/30 Show Home Prev Next End page: GO